Ampalayohan, Laarni Jane G.

HRN: 28-88-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
CO-AMOXICLAV 625MG (TAB)
04/20/2026
04/27/2026
PO
1 Tab
TID
SP NSD ; PROM
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines